GSA Capital Partners’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,029
| Closed | -$1.2M | – | 1710 |
|
|
2025
Q1 | $1.2M | Sell |
41,029
-12,200
| -23% | -$357K | 0.11% | 255 |
|
|
2024
Q4 | $1.75M | Buy |
+53,229
| New | +$1.75M | 0.13% | 123 |
|
|
2024
Q2 | – | Sell |
-30,853
| Closed | -$902K | – | 1590 |
|
|
2024
Q1 | $902K | Sell |
30,853
-73,262
| -70% | -$2.14M | 0.07% | 507 |
|
|
2023
Q4 | $2.32M | Buy |
+104,115
| New | +$2.32M | 0.2% | 79 |
|
|
2022
Q4 | – | Sell |
-8,986
| Closed | -$254K | – | 1413 |
|
|
2022
Q3 | $254K | Buy |
+8,986
| New | +$254K | 0.03% | 1040 |
|
|
2022
Q1 | – | Sell |
-58,059
| Closed | -$1.91M | – | 1370 |
|
|
2021
Q4 | $1.91M | Buy |
+58,059
| New | +$1.91M | 0.24% | 31 |
|
|
2020
Q4 | – | Sell |
-17,552
| Closed | -$614K | – | 1163 |
|
|
2020
Q3 | $614K | Buy |
+17,552
| New | +$614K | 0.1% | 286 |
|
|
2019
Q4 | – | Sell |
-11,764
| Closed | -$381K | – | 1401 |
|
|
2019
Q3 | $381K | Buy |
11,764
+4,236
| +56% | +$137K | 0.05% | 722 |
|
|
2019
Q2 | $375K | Buy |
+7,528
| New | +$375K | 0.04% | 847 |
|
|
2018
Q4 | – | Sell |
-3,400
| Closed | -$262K | – | 1310 |
|
|
2018
Q3 | $262K | Buy |
+3,400
| New | +$262K | 0.01% | 1386 |
|
|
2015
Q4 | – | Sell |
-3,134
| Closed | -$221K | – | 1788 |
|
|
2015
Q3 | $221K | Sell |
3,134
-7,600
| -71% | -$536K | 0.01% | 1525 |
|
|
2015
Q2 | $1.19M | Sell |
10,734
-20,633
| -66% | -$2.29M | 0.05% | 743 |
|
|
2015
Q1 | $2.96M | Buy |
+31,367
| New | +$2.96M | 0.12% | 170 |
|